Nimodipine enhancement of α2 adrenergic modulation of nmda receptor via a mechanism independent of Ca2+ channel blocking

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 8, 2010, Pages 4174-4180

  Dong, Cun Jian ^a   Guo, Yuanxing ^a   Agey, Peter ^a   Wheeler, Larry ^a   Hare, William A ^a  

^a ALLERGAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE ACTIVATOR; ALPHA 2 ADRENERGIC RECEPTOR; ATIPAMEZOLE; BRIMONIDINE; CADMIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM ION; CYCLIC AMP; DILTIAZEM; ISRADIPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NIMODIPINE; VERAPAMIL; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMINO ACID RECEPTOR STIMULATING AGENT; CALCIUM; N METHYLASPARTIC ACID; QUINOXALINE DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CHANNEL GATING; CONTROLLED STUDY; EXCITOTOXICITY; EXPERIMENTAL MODEL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RABBIT; RAT; RETINA GANGLION CELL; RETINOPATHY; SENSORY SYSTEM ELECTROPHYSIOLOGY; SIGNAL TRANSDUCTION; SLOW INWARD CURRENT; VOLTAGE CLAMP; WHOLE CELL; ANIMAL; BROWN NORWAY RAT; CONFOCAL MICROSCOPY; DRUG EFFECT; INJECTION; METABOLISM; RETINA DISEASE; VITREOUS BODY;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; EXCITATORY AMINO ACID AGONISTS; INJECTIONS; MALE; MICROSCOPY, CONFOCAL; N-METHYLASPARTATE; NIMODIPINE; PATCH-CLAMP TECHNIQUES; QUINOXALINES; RABBITS; RATS; RATS, INBRED BN; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, N-METHYL-D-ASPARTATE; RETINAL DISEASES; RETINAL GANGLION CELLS; VITREOUS BODY;

EID: 77955887626     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4613     Document Type: Article

References (34)

1. Docherty JR. Subtypes of functional α1- and α2-adrenoceptors. Eur J Pharmacol. 1998;361:1-15.
2. Peng M, Li Y, Luo Z, Liu C, Laties AM, Wen R. Alpha2-adrenergic agonists selectively activate extracellular signal-regulated kinases in Müller cells in vivo. Invest Ophthalmol Vis Sci. 1998;39:1721-1726.
3. Kalapesi FB, Coroneo MT, Hill MA. Human ganglion cells express the alpha-2 adrenergic receptor: relevance to neuroprotection. Br J Ophthalmol. 2005;89:758-763.
4. Wen R, Cheng T, Li Y, Cao W, Steinberg RH. Alpha 2-adrenergic agonists induce basic fibroblast growth factor expression in photoreceptors in vivo and ameliorate light damage. J Neurosci. 1996; 16:5986-5992.
5. Lai RK, Chun T, Hasson D, Lee S, Mehrbod F, Wheeler L. Alpha-2 adrenoceptor agonist protects retinal function after acute retinal ischemic injury in the rat. Vis Neurosci. 2002;19:175-185.
6. Donello JE, Padillo EU, Webster ML, Wheeler LA, Gil DW. Alpha(2)- Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia. J Pharmacol Exp Ther. 2001;296:216-223.
7. Avilés-Trigueros M, Mayor-Torroglosa S, García-Avilés A, et al. Transient ischemia of the retina results in massive degeneration of the retinotectal projection: long-term neuroprotection with brimonidine. Exp Neurol. 2003;184:767-777.
8. Dong CJ, Guo Y, Agey P, Wheeler L, Hare WA. α2 Adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retina excitotoxicity. Invest Ophthalmol Vis Sci. 2008;49:4515-4522.
9. Yoles E, Wheeler LA, Schwartz M. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest Ophthalmol Vis Sci. 1999;40:65-73.
10. Aktaçs Z, Gürelik G, Akyürek N, Onol M, Hasanreisog̈lu B. Neuroprotective effect of topically applied brimonidine tartrate 0.2% in endothelin-1-induced optic nerve ischaemia model. Clin Exp Ophthalmol. 2007;35:527-534.
11. WoldeMussie E, Ruiz G, Wijono M, Wheeler LA. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Invest Ophthalmol Vis Sci. 2001;42: 2849-2855.
12. Wheeler L, WoldeMussie E, Lai R. Role of alpha-2 agonists in neuroprotection. Surv Ophthalmol. 2003;48 Suppl 1:S47-S51.
13. Hernández M, Urcola JH, Vecino E. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments. Exp Eye Res. 2008;86:798-806.
14. Pan YZ, Li DP, Pan HL. Inhibition of glutamatergic synaptic input to spinal lamina II(o) neurons by presynaptic alpha(2)-adrenergic receptors. J Neurophysiol. 2002;87:1938-1947.
15. Starke K. Presynaptic autoreceptors in the third decade: focus on alpha2-adrenoceptors. J Neurochem. 2001;78:685-693.
16. Ma D, Rajakumaraswamy N, Maze M. α2-Adrenoceptor agonists: shedding light on neuroprotection? Br Med Bull. 2005;71:77-92.
17. Delaney AJ, Crane JW, Sah P. Noradrenaline modulates transmission at a central synapse by a presynaptic mechanism. Neuron. 2007;56:880-892.
18. Delmas P, Abogadie FC, Milligan G, Buckley NJ, Brown DA. Betagamma dimers derived from Go and Gi proteins contribute different components of adrenergic inhibition of Ca2α channels in rat sympathetic neurones. J Physiol. 1999;518:23-36.
19. Vetrugno M, Maino A, Cantatore F, Ruggeri G, Cardia L. Acute and chronic effects of brimonidine 0.2% on intraocular pressure and pulsatile ocular blood flow in patients with primary open-angle glaucoma: an open-label, uncontrolled, prospective study. Clin Ther. 2001;23:1519-1528.
20. Poinoosawmy D, Indar A, Bunce C, Garway-Heath DF, Hitchings RA. Effect of treatment by medicine or surgery on intraocular pressure and pulsatile ocular blood flow in normal-pressure glaucoma. Graefes Arch Clin Exp Ophthalmol. 2002;240:721-726.
21. Evans DW, Hosking SL, Gherghel D, Bartlett JD. Contrast sensitivity improves after brimonidine therapy in primary open angle glaucoma: a case for neuroprotection. Br J Ophthalmol. 2003;87: 1463-1465.
22. Dong CJ, Guo Y, Wheeler L, Hare WA. α2 Adrenergic receptormediated modulation of cytosolic Ca2α signals at the inner plexiform layer of the rat retina. Invest Ophthalmol Vis Sci. 2007;48: 1410-1415.
23. Heidelberger R, Thoreson WB, Witkovsky P. Syanptic transmission at retinal ribbon synpses. Prog Retin Eye Res. 2005;24:682-720.
24. Akopian A, Witkovsky P. Calcium and retinal function. Mol Neurobiol. 2002;25:113-132.
25. Luft FC, Haller H. Calcium channel blockers in current medical practice: an update for 1993. Clin Exp Hypertens. 1993;15:1263-1276.
26. Michalk F, Michelson G, Harazny J, Werner U, Daniel WG, Werner D. Single-dose nimodipine normalizes impaired retinal circulation in normal tension glaucoma. J Glaucoma. 2004;13:158-162.
27. Luksch A, Rainer G, Koyuncu D, et al. Effect of nimodipine on ocular blood flow and colour contrast sensitivity in patients with normal tension glaucoma. Br J Ophthalmol. 2005;89:21-25.
28. Kaya M, Tunc ̧ M, Ozdemir T, Altuntaçs I. Calcium antagonists in N-methyl d-aspartate-induced retinal injury. Graefes Arch Clin Exp Ophthalmol. 2003;241:418-42.
29. Yamada H, Chen YN, Aihara M, Araie M. Neuroprotective effect of calcium channel blocker against retinal ganglion cell damage under hypoxia. Brain Res. 2006;1071:75-80.
30. Grünert U, Haverkamp S, Fletcher EL, Wässle H. Synaptic distribution of ionotropic glutamate receptors in the inner plexiform layer of the primate retina. J Comp Neurol. 2002;447:138-151.
31. Sun D, Rait JL, Kalloniatis M. Inner retinal neurons display differential responses to N-methyl-D-aspartate receptor activation. J Comp Neurol. 2003;465:38-56.
32. Vaney DI, Peichi L, Boycott BB. Matching populations of amacrine cells in the inner nuclear and ganglion cell layers of the rabbit retina. J Comp Neurol. 1981;199:373-391.
33. Vaney DI. 'Coronate' amacrine cells in the rabbit retina have the 'starburst' dendritic morphology. Proc R Soc Lond B Biol Sci. 1984;220:501-508.
34. Tymianski M, Charlton MP, Carlen PL, Tator CH. Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. J Neurosci. 1993;13:2085-2104.